This paper is in the following e-collection/theme issue:

Formative Evaluation of Digital Health Interventions (1740) Mobile Apps for Cancer Care and Cancer Prevention and Screening (173) Patient Education for Cancer (120) User-centred Design Case Studies (497) Design and Formative Evaluation of Mobile Apps (605) Innovations and Technology in Cancer Care (330) Breast Cancer (168)

Published on in Vol 5 , No 3 (2021) :March

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/18325, first published .
Cognitive Bias Modification Training to Improve Implicit Vitality in Patients With Breast Cancer: App Design Using a Cocreation Approach

Cognitive Bias Modification Training to Improve Implicit Vitality in Patients With Breast Cancer: App Design Using a Cocreation Approach

Cognitive Bias Modification Training to Improve Implicit Vitality in Patients With Breast Cancer: App Design Using a Cocreation Approach

Authors of this article:

Roos Wolbers 1, 2 Author Orcid Image ;   Christina Bode 1 Author Orcid Image ;   Ester Siemerink 3 Author Orcid Image ;   Sabine Siesling 4, 5 Author Orcid Image ;   Marcel Pieterse 1 Author Orcid Image
Article Authors Cited by (3) Tweetations (5) Metrics

Journals

  1. Geerts J, Pieterse M, Laverman G, Waanders F, Oosterom N, Slegten J, Salemink E, Bode C. Cognitive Bias Modification Training Targeting Fatigue in Kidney Patients: Usability study (Preprint). JMIR Formative Research 2022 View
  2. Schaap G, Wensink M, Doggen C, van der Palen J, Vonkeman H, Bode C. “It Really Is an Elusive Illness”—Post-COVID-19 Illness Perceptions and Recovery Strategies: A Thematic Analysis. International Journal of Environmental Research and Public Health 2022;19(20):13003 View
  3. Austin J, Drossaert C, van Dijk J, Sanderman R, Børøsund E, Mirkovic J, Schotanus-Dijkstra M, Peeters N, Van 't Klooster J, Schroevers M, Bohlmeijer E. Integrating Top-down and Bottom-up Requirements in eHealth Development: The Case of a Mobile Self-compassion Intervention for People With Newly Diagnosed Cancer. JMIR Cancer 2022;8(3):e37502 View